thromboxanes has been researched along with Lung Diseases, Obstructive in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, FM; Gettinby, G; Lees, P; Page, CP; Rickards, KJ | 1 |
Bailey, SR; Cunningham, FM; Hammond, A; Marr, CM | 1 |
Seale, JP | 1 |
Barnes, NC | 1 |
Alessandri, C; Basili, S; Cipollone, F; Cordova, C; Davì, G; Gazzaniga, P; Santarone, S; Vieri, M; Violi, F | 1 |
Boddi, M; Castellani, S; Fanara, F; Gensini, GF; Neri Serneri, GG; Pezza, A; Prisco, D; Rogasi, PG; Rostagno, C | 1 |
2 review(s) available for thromboxanes and Lung Diseases, Obstructive
Article | Year |
---|---|
Prostaglandins, slow-reacting substances (leukotrienes) and the lung.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Asthma; Bronchi; Epoprostenol; Guinea Pigs; Humans; Indomethacin; Infant, Newborn; Lung; Lung Diseases, Obstructive; Prostaglandin-Endoperoxide Synthases; Prostaglandins; SRS-A; Thromboxanes | 1981 |
New developments in the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Asthma; Humans; Immunosuppression Therapy; Leukotriene Antagonists; Lung Diseases, Obstructive; Platelet Activating Factor; Thromboxanes | 1993 |
4 other study(ies) available for thromboxanes and Lung Diseases, Obstructive
Article | Year |
---|---|
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Administration Schedule; Horse Diseases; Horses; Infusions, Intravenous; Lipopolysaccharides; Lung Diseases, Obstructive; Phosphodiesterase Inhibitors; Rolipram; Thromboxanes | 2003 |
Platelets in equine recurrent airway obstruction.
Topics: Animals; Antigens; Blood Platelets; Horse Diseases; Horses; Hypersensitivity; Lung Diseases, Obstructive; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thromboxanes; Time Factors | 2007 |
Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Topics: Aged; Aspirin; Blood Platelets; Creatinine; Cyclooxygenase Inhibitors; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen Inhalation Therapy; Peptide Fragments; Platelet Activation; Prothrombin; Thromboxane B2; Thromboxanes | 1997 |
Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Topics: beta-Thromboglobulin; Dipyridamole; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |